Related Experiment Video
Updated: Jun 13, 2026

Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase
Matthew W Kellinger1, Kenneth A Johnson
1Institute for Cellular and Molecular Biology, University of Texas, Austin, TX 78712, USA.
Nucleoside analogs like lamivudine triphosphate (3TC-TP) do not bind HIV reverse transcriptase tighter than normal nucleotides (dCTP). Instead, slower incorporation rates explain differences in HIV drug efficacy.
Area of Science:
- Biochemistry
- Enzymology
- Structural Biology
Background:
- Nucleoside analogs are crucial in antiviral therapies, including for HIV.
- Previous studies on HIV reverse transcriptase (HIV RT) kinetics yielded conflicting results regarding nucleotide analog binding affinity.
- Rational structural predictions did not align with observed binding affinities of nucleoside analogs to HIV RT.
Purpose of the Study:
- To resolve controversies surrounding the binding affinities of nucleoside analogs versus normal nucleotides to HIV RT.
- To investigate the kinetic mechanisms governing nucleotide incorporation by HIV RT.
- To elucidate the structural and kinetic basis for the efficacy of nucleoside analog drugs.
Main Methods:
- Utilized single turnover studies to monitor enzyme- kinetics.
- Measured nucleotide-induced changes in HIV reverse transcriptase enzyme structure.
- Analyzed the kinetics of dCTP (deoxycytidine triphosphate) and 3TC-TP (lamivudine triphosphate) incorporation.
Main Results:
- The specificity constant for normal nucleotide (dCTP) incorporation is limited by the binding and isomerization rate, which commits the substrate to reaction.
- Nucleoside analog (3TC-TP) incorporation is slow, allowing conformational changes to reach equilibrium and revealing similar binding affinities to dCTP.
- Previously reported tight binding of analogs was an artifact of incomplete kinetic measurements.
Conclusions:
- dCTP and 3TC-TP exhibit nearly equal binding affinities to HIV RT.
- HIV RT discriminates against 3TC-TP due to its slower incorporation rate, caused by substrate/residue misalignment.
- This kinetic discrimination, not differential binding affinity, underlies the therapeutic effectiveness of nucleoside analogs.
More Related Videos
13:07Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
Published on: January 30, 2019
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Size and Structure of Viral Genomes
DNA Base Pairing
Inhibitors of Virion Maturation and Assembly
Viruses with RNA Genomes
Antiviral Nucleoside Inhibitors
Retrovirus Life Cycles